Sign in
Retinal Nonperfusion and Anti-VEGF Therapy in Diabetic Retinopathy: What We Know and What We Don’t Know
Dante Joseph Pieramici, MD
Updates from the Field
2017
Evaluating Intravitreal ANX007, a Novel C1q Inhibitor, in the Treatment of GA Secondary to AMD: The ARCHER Study
David S. Boyer, MD
2021
Episode 6: YAG Vitreolysis for Symptomatic Floaters with Dr. Chirag Shah
Keyvan Koushan, MD, FRCSC
Member Podcasts
2018
Category: Diabetic Retinopathy